Cultivation Capital

Cultivation Capital is a venture capital firm based in St. Louis, Missouri, founded in 2012. The firm specializes in early-stage investments, primarily targeting Seed to Series B funding rounds. Its investment strategy focuses on technology companies across various sectors, including life sciences, healthcare, agriculture, software, and information technology. Cultivation Capital typically makes initial investments ranging from $100,000 to $3.5 million, with an emphasis on supporting startups in their growth phases. The firm manages multiple funds, including those dedicated to life sciences and technology, aiming to foster innovation and development in these critical industries. As a Registered Investment Adviser, Cultivation Capital is committed to guiding emerging companies toward successful trajectories in the competitive market landscape.

Scott Addonizio

General Partner

Joel Crater

General Partner

Andy Dearing

General Partner

Peter Esparrago

General Partner and Co-Founder

Marc Hirshman

General Partner

Taha Jangda

General Partner

Joe Maxwell

Managing Partner

Jim McKelvey

Co-Founder and General Partner

Paul Meier

Partner

Matt Phimphavong

Principal

Rick Ryan

General Partner

Bobby Sandage

General Partner

Kristina Schmelter

Principal

William Schmidt

General Partner

John True

General Partner

Dean VandeKamp

General Partner

Paul Weber

General Partner

Kyle Welborn

Co-Founder and General Partner

Heather Wood

General Partner

Past deals in Missouri

Clever Real Estate

Venture Round in 2023
Clever Real Estate company that specializes in the fields of commercial real estate and online marketplace. It offers a software platform that guides its users through the process of interviewing real estate agents to find the right one for them. The company was founded in 2017 and headquartered in St Louis, Missouri.

SimpleRose

Venture Round in 2023
SimpleRose Inc. develops and operates optimal decision-making platform. The company's product enables optimal decision-making in complex world where the proliferation of data and growing scope of organizations. The company was incorporated in 2018 and is headquartered in Saint Louis, Missouri.

CuriMeta

Seed Round in 2022
CuriMeta is a advanced real-world health data firm with a focus on life sciences. Driven by the belief that real-world health data maintained within systems of care have unique attributes not found elsewhere, CuriMeta augments, curates, and transforms data from our collaborating data contributors into secure, de-identified, aggregated datasets with high-explanatory power that can be compliantly exchanged with researchers to advance the science of medicine and develop lifesaving cures. With a commitment to full transparency, integrity, and accountability, CuriMeta utilizes a joint governance committee to review all data exchange requests from researchers, and adheres to highly stringent data security, patient privacy, and compliance standards as set forth by our collaborating data contributors, as well as regulatory authorities. By enabling and accelerating the exchange of real-world health data with the research community, our penultimate goal is to provide researchers the indispensable insights and evidence required to solve urgent scientific and clinical challenges and improve healthcare for all.

Crossbar

Seed Round in 2022
Crossbar is a developer of a sports club management platform tailored specifically for youth hockey organizations. The company has established partnerships with nearly 40 clubs across ten states, serving teams that range from 40 to 800 players. Crossbar’s platform features an efficient player registration system and a secure checkout process, along with a syncable calendar that automatically updates each season. This technology allows team owners to streamline their operations, saving time and enhancing management capabilities. Crossbar has registered tens of thousands of players and processed significant transaction volumes, but its primary focus remains on fostering strong relationships within the hockey community, collaborating closely with clubs to address their challenges and improve overall club management.

Battle Bank

Venture Round in 2022
Battle Bank, founded in 2021 and based in Vail, Colorado, aims to provide accessible banking services through a user-friendly financial platform. Although not yet open or approved for operations, the bank plans to offer a range of banking products and intuitive online services designed to enhance client control and reduce fees. With a focus on simple digital banking, Battle Bank seeks to empower users to make informed financial decisions by providing expert advice and support.

Geneoscopy

Series B in 2021
Geneoscopy, LLC is a diagnostic company based in Saint Louis, Missouri, focused on developing non-invasive solutions for gastrointestinal diseases, particularly colorectal cancer. Founded in 2015, Geneoscopy utilizes stool-derived eukaryotic RNA (seRNA) to create a multi-target RNA biomarker panel aimed at identifying colorectal cancer by detecting the effects of cancer-related DNA mutations. The company is committed to improving colorectal cancer screening compliance and facilitating early detection, thereby reducing the associated morbidity and mortality. By employing a novel methodology to extract human RNA transcripts from stool samples, Geneoscopy aims to provide a reliable alternative to traditional colonoscopies, which are often viewed as unpleasant and invasive. In addition to its colorectal cancer diagnostic test, Geneoscopy is also exploring other potential applications of its RNA technology for additional gastrointestinal conditions.

Clever Real Estate

Venture Round in 2021
Clever Real Estate company that specializes in the fields of commercial real estate and online marketplace. It offers a software platform that guides its users through the process of interviewing real estate agents to find the right one for them. The company was founded in 2017 and headquartered in St Louis, Missouri.

Balto

Series B in 2021
Balto Software Inc. is a company that specializes in developing sales software utilizing artificial intelligence and real-time conversation analytics to enhance the performance of sales representatives during phone calls. Founded in 2017 and based in Saint Louis, Missouri, Balto's platform provides live guidance by listening to both sides of a conversation and offering prompts to agents, enabling them to address objections, recognize buyer signals, and maintain an effective dialogue. The software alerts representatives to errors in real-time, allowing for immediate self-correction and ensuring compliance with industry standards. Additionally, it automatically populates dashboards with detailed conversation data for managerial review, helping to identify areas for improvement. Balto's solutions cater to various sectors, including sales leadership, customer service, and compliance, ultimately aiming to improve conversion rates and enhance customer experiences.

Atlas Digital Group

Seed Round in 2021
Atlas Digital Group brings real-world expertise in the design, development and management of industry leading eCommerce solutions, enabling fiber and cable businesses to accelerate growth in the near term and sustain growth over the long-term.

Curate

Seed Round in 2021
Curate is a software as a service (SaaS) company that specializes in event management solutions for professionals in the industry. The company offers a platform that streamlines the planning and execution of events by managing various components such as documents, catering, and rental services. This comprehensive approach allows event professionals to significantly reduce the time spent on generating proposals and facilitates the creation of digital proposals during client consultations. By providing end-to-end event services, Curate enhances the efficiency and effectiveness of event planning and coordination.

SentiAR

Series A in 2021
SentiAR, Inc. is a digital health and software company based in St. Louis, Missouri, focused on enhancing interventional procedures through its innovative 3D augmented reality platform. Incorporated in 2017 and spun out of Washington University, SentiAR develops a holographic visualization system that transforms CT, MRI, and real-time mapping data into interactive 3D holograms. These holograms provide clinicians with a real-time view of the patient's anatomy and catheter positioning, effectively "floating" above the patient, which aids in the treatment and analysis of cardiac arrhythmias. The platform is designed to be fully controllable in a hands-free manner, promoting ergonomic benefits during complex procedures. SentiAR aims to improve the delivery of care for both clinicians and patients and is working towards FDA submission for its technology.

Textel

Series A in 2020
Textel CX Inc. is a company based in Saint Louis, Missouri, that specializes in developing a cloud-based texting platform tailored for contact centers and businesses. Founded in 2014, Textel's platform enhances customer experience and engagement by enabling inbound and outbound SMS and MMS communications. The service allows users to activate texting capabilities on their existing landline and toll-free numbers, facilitating faster customer interactions compared to traditional communication methods like email and voice calls. Textel also provides API integrations and a chatbot solution called Atlas, which assists customers in retail environments. With nearly 800 clients across various sectors, including automotive, insurance, beauty services, pet grooming, healthcare, and legal services, Textel aims to improve contact center performance and workplace productivity.

Paytient

Venture Round in 2020
Paytient Technologies, Inc. is an innovative company that provides a financial platform designed to alleviate the burden of out-of-pocket healthcare expenses for employees. Founded in 2018 and headquartered in Columbia, Missouri, Paytient offers an employer-sponsored payment solution that allows employees to address medical, dental, vision, pharmacy, and veterinary bills. By utilizing the Paytient card, employees can pay these expenses upfront and then repay the amount through interest-free, payroll-deducted payment plans over a set number of pay periods. This approach helps to reduce financial anxiety associated with high-deductible health plans, enabling employees to access necessary care without the stress of immediate out-of-pocket costs.

FinLocker

Series A in 2020
FinLocker is a financial services technology innovator, founded by a team of veterans and executives across the financial services and technology industries. It provides a personal financial assistant tool that enables loans and financial transactions. With consumer consent, FinLocker captures key borrower data and applies intelligent analytics such as loan product recommendations based on a consumer’s financial profile, asset and income verification, and more. The company was founded in 2014 and is headquartered in St Louis, Missouri.

Balto

Series A in 2020
Balto Software Inc. is a company that specializes in developing sales software utilizing artificial intelligence and real-time conversation analytics to enhance the performance of sales representatives during phone calls. Founded in 2017 and based in Saint Louis, Missouri, Balto's platform provides live guidance by listening to both sides of a conversation and offering prompts to agents, enabling them to address objections, recognize buyer signals, and maintain an effective dialogue. The software alerts representatives to errors in real-time, allowing for immediate self-correction and ensuring compliance with industry standards. Additionally, it automatically populates dashboards with detailed conversation data for managerial review, helping to identify areas for improvement. Balto's solutions cater to various sectors, including sales leadership, customer service, and compliance, ultimately aiming to improve conversion rates and enhance customer experiences.

Mission Control

Seed Round in 2020
Mission Control GG, Inc. is a company that designs and develops mobile applications for recreational esports, allowing gamers to join leagues similar to traditional sports leagues. The platform offers a comprehensive League Management solution that enables users to create and manage leagues for popular video games across various platforms. It provides features such as league scheduling, score validation, and champion determination, while also facilitating communication among league members. Organizations, including community groups and colleges, can leverage Mission Control to host leagues, engage participants, and streamline their esports operations. Founded in 2018 and based in Saint Louis, Missouri, Mission Control aims to foster a community-driven environment for gamers to enjoy competitive play with friends and local organizations.

SentiAR

Venture Round in 2020
SentiAR, Inc. is a digital health and software company based in St. Louis, Missouri, focused on enhancing interventional procedures through its innovative 3D augmented reality platform. Incorporated in 2017 and spun out of Washington University, SentiAR develops a holographic visualization system that transforms CT, MRI, and real-time mapping data into interactive 3D holograms. These holograms provide clinicians with a real-time view of the patient's anatomy and catheter positioning, effectively "floating" above the patient, which aids in the treatment and analysis of cardiac arrhythmias. The platform is designed to be fully controllable in a hands-free manner, promoting ergonomic benefits during complex procedures. SentiAR aims to improve the delivery of care for both clinicians and patients and is working towards FDA submission for its technology.

Summersalt

Series B in 2019
Summersalt, LLC is a women's apparel brand established in 2017 and based in Clayton, Missouri. The company specializes in designing, manufacturing, and selling eco-friendly swimwear, activewear, loungewear, travel wear, and sleepwear, all while maintaining an affordable price point. Summersalt's swimwear is crafted from recycled materials and is designed to provide comfort and functionality, including features like chlorine resistance and protection against sand and sweat. The brand is known for its modern and sophisticated styles, backed by extensive data-driven research from millions of measurements collected from thousands of women to ensure an impeccable fit. Summersalt has quickly gained recognition in the fashion industry, attracting a diverse customer base, including influencers and celebrities, and receiving accolades from prominent publications such as ELLE and Vogue. The products are primarily sold online, making them accessible to a wide audience.

LoanNEX

Seed Round in 2019
LoanNEX provides loan discovery and pricing tools to residential mortgage originators. Today’s mortgage business calls for a more diverse approach to the market, and that means delivering a broader selection of products than just agency programs to meet your borrowers needs. LoanNEX provides originators the discovery tools needed to increase their loan volume and serve a broader base of borrowers. Originators can offer more product options to fit all borrowers’ needs and employ the LoanNEX® platform to deliver the right products to their borrowers. A Seamless Solution: The non-agency market is complicated enough. With LoanNEX, there is no long, drawn-out onboarding process. Just sign up and start using it. Our platform is light-touch and intuitive, based on legacy systems, so it is easy for originators to learn and being accessing. Pricing can be adjusted for lender compensation. Simplify the Day-to-Day: Expand your volume opportunity while simplifying your tools. You no longer need to manage multiple portals and platforms to access solutions for expanded credit borrowers. LoanNEX® offers an alternative to working through multiple investors portals to find solutions, allowing originators to do more volume efficiently and confidently.

Textel

Seed Round in 2019
Textel CX Inc. is a company based in Saint Louis, Missouri, that specializes in developing a cloud-based texting platform tailored for contact centers and businesses. Founded in 2014, Textel's platform enhances customer experience and engagement by enabling inbound and outbound SMS and MMS communications. The service allows users to activate texting capabilities on their existing landline and toll-free numbers, facilitating faster customer interactions compared to traditional communication methods like email and voice calls. Textel also provides API integrations and a chatbot solution called Atlas, which assists customers in retail environments. With nearly 800 clients across various sectors, including automotive, insurance, beauty services, pet grooming, healthcare, and legal services, Textel aims to improve contact center performance and workplace productivity.

Healthy Bytes

Series A in 2019
Healthy Bytes, Inc. is a technology company that specializes in personalized nutritional counseling through its innovative platform. Founded in 2014 and headquartered in Saint Louis, Missouri, with an additional office in New York, it connects physicians, employers, and patients to facilitate access to registered dietitians. The platform allows users to schedule private consultations and receive expert guidance tailored to their health needs, particularly for conditions such as obesity, diabetes, high blood pressure, cardiovascular disease, and orthopedic issues. Employees can utilize their existing medical benefits to cover the costs associated with consultations, thereby promoting a healthier workforce through accessible nutritional support.

Geneoscopy

Series A in 2019
Geneoscopy, LLC is a diagnostic company based in Saint Louis, Missouri, focused on developing non-invasive solutions for gastrointestinal diseases, particularly colorectal cancer. Founded in 2015, Geneoscopy utilizes stool-derived eukaryotic RNA (seRNA) to create a multi-target RNA biomarker panel aimed at identifying colorectal cancer by detecting the effects of cancer-related DNA mutations. The company is committed to improving colorectal cancer screening compliance and facilitating early detection, thereby reducing the associated morbidity and mortality. By employing a novel methodology to extract human RNA transcripts from stool samples, Geneoscopy aims to provide a reliable alternative to traditional colonoscopies, which are often viewed as unpleasant and invasive. In addition to its colorectal cancer diagnostic test, Geneoscopy is also exploring other potential applications of its RNA technology for additional gastrointestinal conditions.

Balto

Seed Round in 2019
Balto Software Inc. is a company that specializes in developing sales software utilizing artificial intelligence and real-time conversation analytics to enhance the performance of sales representatives during phone calls. Founded in 2017 and based in Saint Louis, Missouri, Balto's platform provides live guidance by listening to both sides of a conversation and offering prompts to agents, enabling them to address objections, recognize buyer signals, and maintain an effective dialogue. The software alerts representatives to errors in real-time, allowing for immediate self-correction and ensuring compliance with industry standards. Additionally, it automatically populates dashboards with detailed conversation data for managerial review, helping to identify areas for improvement. Balto's solutions cater to various sectors, including sales leadership, customer service, and compliance, ultimately aiming to improve conversion rates and enhance customer experiences.

Paytient

Seed Round in 2019
Paytient Technologies, Inc. is an innovative company that provides a financial platform designed to alleviate the burden of out-of-pocket healthcare expenses for employees. Founded in 2018 and headquartered in Columbia, Missouri, Paytient offers an employer-sponsored payment solution that allows employees to address medical, dental, vision, pharmacy, and veterinary bills. By utilizing the Paytient card, employees can pay these expenses upfront and then repay the amount through interest-free, payroll-deducted payment plans over a set number of pay periods. This approach helps to reduce financial anxiety associated with high-deductible health plans, enabling employees to access necessary care without the stress of immediate out-of-pocket costs.

Clever Real Estate

Series A in 2019
Clever Real Estate company that specializes in the fields of commercial real estate and online marketplace. It offers a software platform that guides its users through the process of interviewing real estate agents to find the right one for them. The company was founded in 2017 and headquartered in St Louis, Missouri.

Nanoguard Technologies

Series A in 2019
Nanoguard Technologies is developing cold plasma technology for the treatment of grains. Its cold plasma technology facilitates food sanitation technology which is designed to preserve the freshness and wholesomeness of food while improving its safety from food borne illness, providing food growers with a safe, cost efficient, and environmentally friendly tool to manage and reduce mycotoxins. Nanoguard Technologies was founded on 2014 and is headquartered Saint Louis, Missouri.

Well Principled

Pre Seed Round in 2019
Well Principled Corp. is an artificial intelligence management consulting firm based in St. Louis, Missouri, founded in 2018. The company focuses on assisting chief marketing officers and chief supply chain officers by predicting customer buying behavior and optimizing marketing and supply chain processes for retail and consumer packaged goods brands. Its AI-driven software leverages data to deliver actionable insights grounded in academic business theories. By analyzing key factors such as customer retention, pricing, and product development, Well Principled provides businesses with strategic plans that enhance operational efficiency without the need for extensive analyst teams or traditional management consultants. This innovative approach enables brands to improve their growth and streamline operations in various areas, including retail assortments and advertising expenditures.

Arch Oncology

Series B in 2019
Arch Oncology is an immuno-oncology company focused on developing anti-CD47 antibodies for the treatment of solid and hematologic cancers. Founded in 2006 and based in St. Louis, Missouri, with a corporate office in Brisbane, California, the company aims to create innovative therapies that leverage both adaptive and innate immune responses. Arch Oncology's approach involves a new class of checkpoint inhibitors, which represents a significant advancement in cancer treatment. Through its research and development efforts, the company seeks to improve outcomes for patients battling various forms of cancer.

Aggio

Seed Round in 2019
Aggio, LLC is an information technology company that specializes in developing cloud-based sales applications tailored for the agriculture industry. Established in 2016 and headquartered in St. Louis, Missouri, with an additional location in Madison, New Jersey, Aggio offers a platform designed to enhance marketing and sales processes. Its solutions facilitate data-driven decision-making through advanced analytics, data harmonization, and visualization, enabling clients to effectively engage their customers and channel partners.

Curate

Seed Round in 2018
Curate is a software as a service (SaaS) company that specializes in event management solutions for professionals in the industry. The company offers a platform that streamlines the planning and execution of events by managing various components such as documents, catering, and rental services. This comprehensive approach allows event professionals to significantly reduce the time spent on generating proposals and facilitates the creation of digital proposals during client consultations. By providing end-to-end event services, Curate enhances the efficiency and effectiveness of event planning and coordination.

Clever Real Estate

Venture Round in 2018
Clever Real Estate company that specializes in the fields of commercial real estate and online marketplace. It offers a software platform that guides its users through the process of interviewing real estate agents to find the right one for them. The company was founded in 2017 and headquartered in St Louis, Missouri.

CoverCress

Venture Round in 2018
CoverCress is a biotechnology company that focuses on research and development of renewable fuel and livestock feed. It specializes in producing an oilseed crop for food, bioenergy, and cattle feed. It specializes in the fields of agriculture, biotechnology, plants, genetics, cover crop, and precision agriculture. CoverCress was founded in 2013 by Jerry Steiner and Dr. Tim Ulmasov and is headquartered in St. Louis Missouri.

Summersalt

Series A in 2018
Summersalt, LLC is a women's apparel brand established in 2017 and based in Clayton, Missouri. The company specializes in designing, manufacturing, and selling eco-friendly swimwear, activewear, loungewear, travel wear, and sleepwear, all while maintaining an affordable price point. Summersalt's swimwear is crafted from recycled materials and is designed to provide comfort and functionality, including features like chlorine resistance and protection against sand and sweat. The brand is known for its modern and sophisticated styles, backed by extensive data-driven research from millions of measurements collected from thousands of women to ensure an impeccable fit. Summersalt has quickly gained recognition in the fashion industry, attracting a diverse customer base, including influencers and celebrities, and receiving accolades from prominent publications such as ELLE and Vogue. The products are primarily sold online, making them accessible to a wide audience.

SimpleRose

Venture Round in 2018
SimpleRose Inc. develops and operates optimal decision-making platform. The company's product enables optimal decision-making in complex world where the proliferation of data and growing scope of organizations. The company was incorporated in 2018 and is headquartered in Saint Louis, Missouri.

CareSignal

Seed Round in 2018
CareSignal is a provider of a remote patient monitoring platform designed to enhance the performance of payers and providers in value-based care. The platform engages large patient populations through disease-specific, evidence-based automated communications via text messages and phone calls. By identifying rising-risk patients, CareSignal enables care teams to receive real-time alerts, allowing for timely prioritization and outreach. This approach helps address the needs of underserved populations and their safety-net providers, as patients can utilize their existing phones to interact with the system. Ultimately, CareSignal aims to facilitate proactive care for individuals facing chronic, behavioral, and social challenges.

iSite Media

Seed Round in 2018
iSite Media, LLC specializes in advertising and marketing through digital display technology, primarily focusing on a unique digital display network located in restrooms of high-traffic venues. Founded in 2015 and based in St. Louis, Missouri, iSite Media aims to connect brands with a captive audience by delivering impactful video messages in strategic environments. The company's approach enhances brand visibility while providing aesthetic upgrades to venues, such as stadiums and arenas, which also allows these locations to generate additional revenue. By targeting specific audiences in confined spaces, iSite Media ensures high relevance and recall, making it an effective choice for advertisers seeking to maximize the effectiveness of their media campaigns. Formerly known as Sitting Duck Advertising, the company rebranded to iSite Media in 2017.

FinLocker

Seed Round in 2018
FinLocker is a financial services technology innovator, founded by a team of veterans and executives across the financial services and technology industries. It provides a personal financial assistant tool that enables loans and financial transactions. With consumer consent, FinLocker captures key borrower data and applies intelligent analytics such as loan product recommendations based on a consumer’s financial profile, asset and income verification, and more. The company was founded in 2014 and is headquartered in St Louis, Missouri.

SentiAR

Convertible Note in 2018
SentiAR, Inc. is a digital health and software company based in St. Louis, Missouri, focused on enhancing interventional procedures through its innovative 3D augmented reality platform. Incorporated in 2017 and spun out of Washington University, SentiAR develops a holographic visualization system that transforms CT, MRI, and real-time mapping data into interactive 3D holograms. These holograms provide clinicians with a real-time view of the patient's anatomy and catheter positioning, effectively "floating" above the patient, which aids in the treatment and analysis of cardiac arrhythmias. The platform is designed to be fully controllable in a hands-free manner, promoting ergonomic benefits during complex procedures. SentiAR aims to improve the delivery of care for both clinicians and patients and is working towards FDA submission for its technology.

Summersalt

Seed Round in 2018
Summersalt, LLC is a women's apparel brand established in 2017 and based in Clayton, Missouri. The company specializes in designing, manufacturing, and selling eco-friendly swimwear, activewear, loungewear, travel wear, and sleepwear, all while maintaining an affordable price point. Summersalt's swimwear is crafted from recycled materials and is designed to provide comfort and functionality, including features like chlorine resistance and protection against sand and sweat. The brand is known for its modern and sophisticated styles, backed by extensive data-driven research from millions of measurements collected from thousands of women to ensure an impeccable fit. Summersalt has quickly gained recognition in the fashion industry, attracting a diverse customer base, including influencers and celebrities, and receiving accolades from prominent publications such as ELLE and Vogue. The products are primarily sold online, making them accessible to a wide audience.

Aptimmune

Series B in 2018
Aptimmune Biologics Inc. is a biotechnology company dedicated to the development of prophylactic measures against viral diseases affecting swine. Founded in 2010, the company focuses on creating innovative mucosal vaccines to prevent significant diseases such as Porcine Reproductive and Respiratory Syndrome virus (PRRSV) and influenza. Aptimmune employs novel technologies, including a proprietary pig alveolar macrophage cell line known as ZMAC, to enhance the efficacy of its nasal delivery vaccines. While the company was originally based in St. Louis, Missouri, its operations are currently located in Champaign, Illinois.

Decide

Seed Round in 2017
Decide operates an interest-based social platform that caters to various topics, including gaming, music, and politics. The company provides native advertising solutions that allow brands to effectively engage with their target audiences. It offers tools for audience development, such as polls, contests, quizzes, and feedback mechanisms, enabling publishers to activate user engagement through customizable actions like newsletter subscriptions and social media follows. Additionally, Decide assists in campaign planning, content creation, and performance optimization, while allowing real-time measurement of results. The platform leverages an in-house artificial intelligence, known as Neo, which utilizes machine learning to analyze vast amounts of data and make informed advertising decisions. Founded in 2008 and headquartered in Saint Louis, Missouri, with an additional office in New York, Decide aims to enhance the advertising experience by connecting advertisers with relevant publishers and users.

SentiAR

Seed Round in 2017
SentiAR, Inc. is a digital health and software company based in St. Louis, Missouri, focused on enhancing interventional procedures through its innovative 3D augmented reality platform. Incorporated in 2017 and spun out of Washington University, SentiAR develops a holographic visualization system that transforms CT, MRI, and real-time mapping data into interactive 3D holograms. These holograms provide clinicians with a real-time view of the patient's anatomy and catheter positioning, effectively "floating" above the patient, which aids in the treatment and analysis of cardiac arrhythmias. The platform is designed to be fully controllable in a hands-free manner, promoting ergonomic benefits during complex procedures. SentiAR aims to improve the delivery of care for both clinicians and patients and is working towards FDA submission for its technology.

Indalo Therapeutics

Venture Round in 2017
Indalo Therapeutics is a preclinical-stage biotechnology company focused on developing innovative therapies for patients afflicted by fibrotic diseases. Founded on significant scientific advancements, the company leverages deep insights into the molecular mechanisms that drive abnormal scarring. By assembling a skilled team of pharmaceutical scientists and industry executives, Indalo aims to address critical unmet medical needs in the field of fibrosis. Its therapeutic approach seeks to not only halt but also potentially reverse the progression of fibrotic conditions, ultimately improving the quality of life for affected individuals.

CoverCress

Venture Round in 2017
CoverCress is a biotechnology company that focuses on research and development of renewable fuel and livestock feed. It specializes in producing an oilseed crop for food, bioenergy, and cattle feed. It specializes in the fields of agriculture, biotechnology, plants, genetics, cover crop, and precision agriculture. CoverCress was founded in 2013 by Jerry Steiner and Dr. Tim Ulmasov and is headquartered in St. Louis Missouri.

BenchmarkONE

Series A in 2017
BenchmarkONE is sales and marketing software for small businesses and marketing agencies. We help agencies and small business owners propel relationships into sales with all-in-one CRM and marketing automation. Cut through the clutter and complexity of bulky tools with a simple, affordable platform made for you.

TopOPPS

Venture Round in 2016
TopOPPS, Inc. specializes in providing predictive analytics solutions for sales forecasting and pipeline management tailored for business-to-business companies. Its primary product, TopOPPS, enhances visibility into the sales process by analyzing key activities, improving forecasting accuracy, and identifying coaching opportunities for sales teams. Additionally, the TopOPPS Rep Assistant captures relevant data from Gmail and updates Salesforce in real time, streamlining the workflow for sales representatives. The company's offerings aim to deliver clarity, efficiency, and predictability in sales processes, ultimately leading to increased success rates and expedited sales cycles. Founded in 2013 and headquartered in St. Louis, Missouri, TopOPPS has established a strategic partnership with Brainshark, Inc. to further enhance its services.

Euclises

Venture Round in 2016
Euclises Pharmaceuticals, Inc is developing novel pain and cancer medications that offer superior safety margins compared to existing drugs. The company is based on new inventions from Dr. John Talley, the most accomplished medicinal chemist in the world. Dr. Talley previously invented Celebrex and seven other approved drugs. New compounds from Euclises will offer both improved efficacy and safety relative to existing therapies. Euclises is located at the BioGenerator Accelerator Labs.

FinLocker

Seed Round in 2016
FinLocker is a financial services technology innovator, founded by a team of veterans and executives across the financial services and technology industries. It provides a personal financial assistant tool that enables loans and financial transactions. With consumer consent, FinLocker captures key borrower data and applies intelligent analytics such as loan product recommendations based on a consumer’s financial profile, asset and income verification, and more. The company was founded in 2014 and is headquartered in St Louis, Missouri.

Arch Oncology

Series A in 2016
Arch Oncology is an immuno-oncology company focused on developing anti-CD47 antibodies for the treatment of solid and hematologic cancers. Founded in 2006 and based in St. Louis, Missouri, with a corporate office in Brisbane, California, the company aims to create innovative therapies that leverage both adaptive and innate immune responses. Arch Oncology's approach involves a new class of checkpoint inhibitors, which represents a significant advancement in cancer treatment. Through its research and development efforts, the company seeks to improve outcomes for patients battling various forms of cancer.

BlueStrata

Seed Round in 2016
BlueStrata EHR is a St. Louis-based company that specializes in cloud-based electronic health records software tailored for long-term care and resident care facilities. The platform integrates clinical, financial, and point-of-care services, which facilitates seamless data sharing across medical records and billing systems. By employing a Software as a Service model, BlueStrata's EHR system enables healthcare providers to efficiently maintain patient records and manage billing processes. The technology is designed for ease of use, featuring touch screen kiosks that allow caregivers to accurately capture resident care information from any location. Since August 2018, BlueStrata EHR has operated as a subsidiary of Mediware Information Systems, Inc.

Sequoia Sciences

Seed Round in 2016
Sequoia Sciences, Inc. is a pharmaceutical company based in Saint Louis, Missouri, focused on discovering and developing innovative treatments for bacterial infections and cancers. Founded in 1999, the company engages in preclinical development programs aimed at addressing unmet medical needs, particularly for lung infections in cystic fibrosis patients and recurrent urinary tract infections. Sequoia's portfolio includes small molecules and vaccines designed to improve the quality of life for individuals affected by chronic bacterial infections and cancers. The company collaborates with laboratories, universities, clinical research sites, and private enterprises to advance its research and development efforts. Additionally, Sequoia applies its expertise in microscale structure determination to elucidate the structures of natural products and synthetic intermediates, supporting both academic and industrial research initiatives.

Euclises

Venture Round in 2016
Euclises Pharmaceuticals, Inc is developing novel pain and cancer medications that offer superior safety margins compared to existing drugs. The company is based on new inventions from Dr. John Talley, the most accomplished medicinal chemist in the world. Dr. Talley previously invented Celebrex and seven other approved drugs. New compounds from Euclises will offer both improved efficacy and safety relative to existing therapies. Euclises is located at the BioGenerator Accelerator Labs.

Adarza BioSystems

Series B in 2016
Adarza BioSystems is an early-stage medical diagnostics company developing a rapid and label-free biological assay platform for measuring clinical and point-of-care (POC) samples. In addition to performing sophisticated clinical tests within minutes, this technology potentially allowing hundreds of tests to be run simultaneously on a single chip. It was founded in 2008 and headquartered in St Louis, Missouri.

FinLocker

Seed Round in 2016
FinLocker is a financial services technology innovator, founded by a team of veterans and executives across the financial services and technology industries. It provides a personal financial assistant tool that enables loans and financial transactions. With consumer consent, FinLocker captures key borrower data and applies intelligent analytics such as loan product recommendations based on a consumer’s financial profile, asset and income verification, and more. The company was founded in 2014 and is headquartered in St Louis, Missouri.

Gremlin Social

Series A in 2016
Gremlin Social provides an integrated platform designed for financial institutions to enhance their social media marketing efforts. It offers organizational tools that consolidate management of Twitter, Facebook, and LinkedIn into a single, user-friendly dashboard. Users can engage with customers, monitor brand mentions, and efficiently schedule posts, optimizing time spent on social media to as little as 15 minutes a day. The platform is particularly tailored for banks and financial services, featuring capabilities such as team management, keyword filtration, and analytics, along with enterprise and white-label options. Gremlin Social is recognized by the American Bankers Association and the New York Bankers Association as a recommended solution for social media management and compliance. Additionally, the company provides expertise in strategy, training, and research to further support its clients in navigating social media best practices.

Euphrates Vascular

Venture Round in 2016
As of January 8, 2019, Pulse Therapeutics, Inc. was acquired by Ichor Vascular, Inc. Pulse Therapeutics, Inc., a medical technology company, develops magnetically-enhanced diffusion (MED) system for the treatment of stroke, heart, and other diseases. Its MED system is used to harness magnet-based technology to dissolve blood clots faster than current modalities. The company also provides MED MicroBeads that are designed to convey physician-selected agents faster to the blood clot; intravenously administered after thrombolysis therapy is initiated; and mechanical adjunct to standard of care IV thrombolysis. In addition, it offers touch screen operated MED Workstation. Pulse Therapeutics, Inc. was incorporated in 2008 and is based in St. Louis, Missouri.

Euclises

Venture Round in 2015
Euclises Pharmaceuticals, Inc is developing novel pain and cancer medications that offer superior safety margins compared to existing drugs. The company is based on new inventions from Dr. John Talley, the most accomplished medicinal chemist in the world. Dr. Talley previously invented Celebrex and seven other approved drugs. New compounds from Euclises will offer both improved efficacy and safety relative to existing therapies. Euclises is located at the BioGenerator Accelerator Labs.

BenchmarkONE

Seed Round in 2015
BenchmarkONE is sales and marketing software for small businesses and marketing agencies. We help agencies and small business owners propel relationships into sales with all-in-one CRM and marketing automation. Cut through the clutter and complexity of bulky tools with a simple, affordable platform made for you.

TopOPPS

Seed Round in 2015
TopOPPS, Inc. specializes in providing predictive analytics solutions for sales forecasting and pipeline management tailored for business-to-business companies. Its primary product, TopOPPS, enhances visibility into the sales process by analyzing key activities, improving forecasting accuracy, and identifying coaching opportunities for sales teams. Additionally, the TopOPPS Rep Assistant captures relevant data from Gmail and updates Salesforce in real time, streamlining the workflow for sales representatives. The company's offerings aim to deliver clarity, efficiency, and predictability in sales processes, ultimately leading to increased success rates and expedited sales cycles. Founded in 2013 and headquartered in St. Louis, Missouri, TopOPPS has established a strategic partnership with Brainshark, Inc. to further enhance its services.

Benson Hill

Series A in 2015
Benson Hill is an agricultural technology company focused on crop improvement, particularly in soy protein innovation. By leveraging its proprietary CropOS™ platform, the company integrates machine learning, genomic data, and traditional breeding techniques to streamline the development of healthier and more sustainable food products. Benson Hill emphasizes unlocking the natural genetic diversity of plants to empower innovators in creating flavorful and nutritious ingredients. The company operates a Crop Accelerator for rapid prototyping and is developing a diverse seed portfolio that includes protein ingredients, aquaculture, specialty animal feed, and vegetable oils. Its revenue is generated from both proprietary and non-proprietary product categories, reflecting its commitment to advancing agricultural innovation.

BlueStrata

Seed Round in 2015
BlueStrata EHR is a St. Louis-based company that specializes in cloud-based electronic health records software tailored for long-term care and resident care facilities. The platform integrates clinical, financial, and point-of-care services, which facilitates seamless data sharing across medical records and billing systems. By employing a Software as a Service model, BlueStrata's EHR system enables healthcare providers to efficiently maintain patient records and manage billing processes. The technology is designed for ease of use, featuring touch screen kiosks that allow caregivers to accurately capture resident care information from any location. Since August 2018, BlueStrata EHR has operated as a subsidiary of Mediware Information Systems, Inc.

Arch Oncology

Venture Round in 2015
Arch Oncology is an immuno-oncology company focused on developing anti-CD47 antibodies for the treatment of solid and hematologic cancers. Founded in 2006 and based in St. Louis, Missouri, with a corporate office in Brisbane, California, the company aims to create innovative therapies that leverage both adaptive and innate immune responses. Arch Oncology's approach involves a new class of checkpoint inhibitors, which represents a significant advancement in cancer treatment. Through its research and development efforts, the company seeks to improve outcomes for patients battling various forms of cancer.

Tunespeak

Series A in 2015
Tunespeak, LLC operates a musician-to-fan loyalty platform designed to engage users through various media interactions. Founded in 2011 and based in St. Louis, Missouri, the platform allows users to earn points by listening to music, watching videos, and sharing content with friends and followers. Additionally, it enables users' friends to accumulate points for a contestant based on their interactions with songs, pictures, and videos throughout contests or raffles. By fostering a deeper connection between musicians and their fans, Tunespeak enhances fan engagement and loyalty in the music industry.

CoverCress

Series A in 2015
CoverCress is a biotechnology company that focuses on research and development of renewable fuel and livestock feed. It specializes in producing an oilseed crop for food, bioenergy, and cattle feed. It specializes in the fields of agriculture, biotechnology, plants, genetics, cover crop, and precision agriculture. CoverCress was founded in 2013 by Jerry Steiner and Dr. Tim Ulmasov and is headquartered in St. Louis Missouri.

BenchmarkONE

Venture Round in 2015
BenchmarkONE is sales and marketing software for small businesses and marketing agencies. We help agencies and small business owners propel relationships into sales with all-in-one CRM and marketing automation. Cut through the clutter and complexity of bulky tools with a simple, affordable platform made for you.

Euclises

Series A in 2015
Euclises Pharmaceuticals, Inc is developing novel pain and cancer medications that offer superior safety margins compared to existing drugs. The company is based on new inventions from Dr. John Talley, the most accomplished medicinal chemist in the world. Dr. Talley previously invented Celebrex and seven other approved drugs. New compounds from Euclises will offer both improved efficacy and safety relative to existing therapies. Euclises is located at the BioGenerator Accelerator Labs.

TopOPPS

Seed Round in 2015
TopOPPS, Inc. specializes in providing predictive analytics solutions for sales forecasting and pipeline management tailored for business-to-business companies. Its primary product, TopOPPS, enhances visibility into the sales process by analyzing key activities, improving forecasting accuracy, and identifying coaching opportunities for sales teams. Additionally, the TopOPPS Rep Assistant captures relevant data from Gmail and updates Salesforce in real time, streamlining the workflow for sales representatives. The company's offerings aim to deliver clarity, efficiency, and predictability in sales processes, ultimately leading to increased success rates and expedited sales cycles. Founded in 2013 and headquartered in St. Louis, Missouri, TopOPPS has established a strategic partnership with Brainshark, Inc. to further enhance its services.

Immunophotonics

Series A in 2015
ImmunoPhotonics, Inc. is a biotechnology company focused on developing innovative immunotherapy treatments for metastatic solid tumor cancers. Founded in 2008 and based in Missouri, the company specializes in a proprietary drug product designed for use as an in situ autologous cancer vaccine. This product utilizes a carbohydrate polymer that is intratumorally injected following tumor ablation. By leveraging the tumor-associated neoantigens released during the ablation process, the treatment aims to induce a systemic anti-tumor immune response. ImmunoPhotonics has also formed a strategic partnership with Veterinary Cancer Therapeutics, LLC to further its research and development efforts in cancer therapy.

Decide

Series B in 2014
Decide operates an interest-based social platform that caters to various topics, including gaming, music, and politics. The company provides native advertising solutions that allow brands to effectively engage with their target audiences. It offers tools for audience development, such as polls, contests, quizzes, and feedback mechanisms, enabling publishers to activate user engagement through customizable actions like newsletter subscriptions and social media follows. Additionally, Decide assists in campaign planning, content creation, and performance optimization, while allowing real-time measurement of results. The platform leverages an in-house artificial intelligence, known as Neo, which utilizes machine learning to analyze vast amounts of data and make informed advertising decisions. Founded in 2008 and headquartered in Saint Louis, Missouri, with an additional office in New York, Decide aims to enhance the advertising experience by connecting advertisers with relevant publishers and users.

TrackBill

Seed Round in 2014
TrackBill provides government affairs professionals with efficient mobile access to state and federal legislative information. It serves a diverse clientele, including professional service firms, corporations, and interest groups, enabling them to monitor bills relevant to their interests and track legislative activities. Users benefit from real-time alerts on key actions such as introductions, amendments, hearings, and votes. Additionally, TrackBill simplifies legislative reporting by allowing users to generate professional documents in Word, PDF, and Excel formats, as well as customizable, auto-updating website feeds. This functionality ensures that stakeholders remain informed about important legislative developments.

Gremlin Social

Seed Round in 2014
Gremlin Social provides an integrated platform designed for financial institutions to enhance their social media marketing efforts. It offers organizational tools that consolidate management of Twitter, Facebook, and LinkedIn into a single, user-friendly dashboard. Users can engage with customers, monitor brand mentions, and efficiently schedule posts, optimizing time spent on social media to as little as 15 minutes a day. The platform is particularly tailored for banks and financial services, featuring capabilities such as team management, keyword filtration, and analytics, along with enterprise and white-label options. Gremlin Social is recognized by the American Bankers Association and the New York Bankers Association as a recommended solution for social media management and compliance. Additionally, the company provides expertise in strategy, training, and research to further support its clients in navigating social media best practices.

Adarza BioSystems

Series A in 2014
Adarza BioSystems is an early-stage medical diagnostics company developing a rapid and label-free biological assay platform for measuring clinical and point-of-care (POC) samples. In addition to performing sophisticated clinical tests within minutes, this technology potentially allowing hundreds of tests to be run simultaneously on a single chip. It was founded in 2008 and headquartered in St Louis, Missouri.

TopOPPS

Seed Round in 2014
TopOPPS, Inc. specializes in providing predictive analytics solutions for sales forecasting and pipeline management tailored for business-to-business companies. Its primary product, TopOPPS, enhances visibility into the sales process by analyzing key activities, improving forecasting accuracy, and identifying coaching opportunities for sales teams. Additionally, the TopOPPS Rep Assistant captures relevant data from Gmail and updates Salesforce in real time, streamlining the workflow for sales representatives. The company's offerings aim to deliver clarity, efficiency, and predictability in sales processes, ultimately leading to increased success rates and expedited sales cycles. Founded in 2013 and headquartered in St. Louis, Missouri, TopOPPS has established a strategic partnership with Brainshark, Inc. to further enhance its services.

Euclises

Series A in 2014
Euclises Pharmaceuticals, Inc is developing novel pain and cancer medications that offer superior safety margins compared to existing drugs. The company is based on new inventions from Dr. John Talley, the most accomplished medicinal chemist in the world. Dr. Talley previously invented Celebrex and seven other approved drugs. New compounds from Euclises will offer both improved efficacy and safety relative to existing therapies. Euclises is located at the BioGenerator Accelerator Labs.

Immunophotonics

Series A in 2014
ImmunoPhotonics, Inc. is a biotechnology company focused on developing innovative immunotherapy treatments for metastatic solid tumor cancers. Founded in 2008 and based in Missouri, the company specializes in a proprietary drug product designed for use as an in situ autologous cancer vaccine. This product utilizes a carbohydrate polymer that is intratumorally injected following tumor ablation. By leveraging the tumor-associated neoantigens released during the ablation process, the treatment aims to induce a systemic anti-tumor immune response. ImmunoPhotonics has also formed a strategic partnership with Veterinary Cancer Therapeutics, LLC to further its research and development efforts in cancer therapy.

BenchmarkONE

Seed Round in 2014
BenchmarkONE is sales and marketing software for small businesses and marketing agencies. We help agencies and small business owners propel relationships into sales with all-in-one CRM and marketing automation. Cut through the clutter and complexity of bulky tools with a simple, affordable platform made for you.

Adarza BioSystems

Series A in 2014
Adarza BioSystems is an early-stage medical diagnostics company developing a rapid and label-free biological assay platform for measuring clinical and point-of-care (POC) samples. In addition to performing sophisticated clinical tests within minutes, this technology potentially allowing hundreds of tests to be run simultaneously on a single chip. It was founded in 2008 and headquartered in St Louis, Missouri.

Tunespeak

Seed Round in 2014
Tunespeak, LLC operates a musician-to-fan loyalty platform designed to engage users through various media interactions. Founded in 2011 and based in St. Louis, Missouri, the platform allows users to earn points by listening to music, watching videos, and sharing content with friends and followers. Additionally, it enables users' friends to accumulate points for a contestant based on their interactions with songs, pictures, and videos throughout contests or raffles. By fostering a deeper connection between musicians and their fans, Tunespeak enhances fan engagement and loyalty in the music industry.

TopOPPS

Seed Round in 2014
TopOPPS, Inc. specializes in providing predictive analytics solutions for sales forecasting and pipeline management tailored for business-to-business companies. Its primary product, TopOPPS, enhances visibility into the sales process by analyzing key activities, improving forecasting accuracy, and identifying coaching opportunities for sales teams. Additionally, the TopOPPS Rep Assistant captures relevant data from Gmail and updates Salesforce in real time, streamlining the workflow for sales representatives. The company's offerings aim to deliver clarity, efficiency, and predictability in sales processes, ultimately leading to increased success rates and expedited sales cycles. Founded in 2013 and headquartered in St. Louis, Missouri, TopOPPS has established a strategic partnership with Brainshark, Inc. to further enhance its services.

Euphrates Vascular

Venture Round in 2014
As of January 8, 2019, Pulse Therapeutics, Inc. was acquired by Ichor Vascular, Inc. Pulse Therapeutics, Inc., a medical technology company, develops magnetically-enhanced diffusion (MED) system for the treatment of stroke, heart, and other diseases. Its MED system is used to harness magnet-based technology to dissolve blood clots faster than current modalities. The company also provides MED MicroBeads that are designed to convey physician-selected agents faster to the blood clot; intravenously administered after thrombolysis therapy is initiated; and mechanical adjunct to standard of care IV thrombolysis. In addition, it offers touch screen operated MED Workstation. Pulse Therapeutics, Inc. was incorporated in 2008 and is based in St. Louis, Missouri.

TrackBill

Seed Round in 2013
TrackBill provides government affairs professionals with efficient mobile access to state and federal legislative information. It serves a diverse clientele, including professional service firms, corporations, and interest groups, enabling them to monitor bills relevant to their interests and track legislative activities. Users benefit from real-time alerts on key actions such as introductions, amendments, hearings, and votes. Additionally, TrackBill simplifies legislative reporting by allowing users to generate professional documents in Word, PDF, and Excel formats, as well as customizable, auto-updating website feeds. This functionality ensures that stakeholders remain informed about important legislative developments.

Mobius Therapeutics

Series B in 2013
Mobius Therapeutics, LLC is a St. Louis-based company that specializes in developing sterile injectable pharmaceutical products for ophthalmic applications. Founded in 2006, the company focuses on delivering innovative solutions for ophthalmic surgery, with its flagship product, Mitosol, designed for the safe delivery of mitomycin, an antifibrotic agent, during glaucoma, refractive, and corneal surgeries. Mitosol includes a closed-system transfer device and sponge tray, facilitating the safe reconstitution and transfer of the medication. Additionally, Mobius Therapeutics offers Amphadase, a hyaluronidase injection. The company aims to enhance patient care by providing ophthalmologists with effective surgical solutions, and its products are available for purchase online.

Aisle411

Series A in 2013
Aisle411 Inc., founded in 2008 and headquartered in St. Louis, Missouri, specializes in providing mobile in-store location services for retailers. The company's innovative platform enables shoppers to easily navigate retail environments by mapping products, offers, and shopping lists based on aisle location. It enhances the shopping experience by delivering contextually relevant information to consumers as they move through stores. For retailers, Aisle411's technology helps them engage shoppers at the shelf, facilitating access to product inventory and location data. The platform is designed to collect and organize this information, allowing for improved merchandising insights and customer engagement. Additionally, Aisle411 collaborates with leading indoor positioning technology providers to enhance its services, ultimately driving higher customer satisfaction and simplifying the overall shopping experience.

TrackBill

Seed Round in 2013
TrackBill provides government affairs professionals with efficient mobile access to state and federal legislative information. It serves a diverse clientele, including professional service firms, corporations, and interest groups, enabling them to monitor bills relevant to their interests and track legislative activities. Users benefit from real-time alerts on key actions such as introductions, amendments, hearings, and votes. Additionally, TrackBill simplifies legislative reporting by allowing users to generate professional documents in Word, PDF, and Excel formats, as well as customizable, auto-updating website feeds. This functionality ensures that stakeholders remain informed about important legislative developments.

Tunespeak

Seed Round in 2013
Tunespeak, LLC operates a musician-to-fan loyalty platform designed to engage users through various media interactions. Founded in 2011 and based in St. Louis, Missouri, the platform allows users to earn points by listening to music, watching videos, and sharing content with friends and followers. Additionally, it enables users' friends to accumulate points for a contestant based on their interactions with songs, pictures, and videos throughout contests or raffles. By fostering a deeper connection between musicians and their fans, Tunespeak enhances fan engagement and loyalty in the music industry.

Decide

Series A in 2013
Decide operates an interest-based social platform that caters to various topics, including gaming, music, and politics. The company provides native advertising solutions that allow brands to effectively engage with their target audiences. It offers tools for audience development, such as polls, contests, quizzes, and feedback mechanisms, enabling publishers to activate user engagement through customizable actions like newsletter subscriptions and social media follows. Additionally, Decide assists in campaign planning, content creation, and performance optimization, while allowing real-time measurement of results. The platform leverages an in-house artificial intelligence, known as Neo, which utilizes machine learning to analyze vast amounts of data and make informed advertising decisions. Founded in 2008 and headquartered in Saint Louis, Missouri, with an additional office in New York, Decide aims to enhance the advertising experience by connecting advertisers with relevant publishers and users.

BenchmarkONE

Seed Round in 2012
BenchmarkONE is sales and marketing software for small businesses and marketing agencies. We help agencies and small business owners propel relationships into sales with all-in-one CRM and marketing automation. Cut through the clutter and complexity of bulky tools with a simple, affordable platform made for you.

Aisle411

Angel Round in 2012
Aisle411 Inc., founded in 2008 and headquartered in St. Louis, Missouri, specializes in providing mobile in-store location services for retailers. The company's innovative platform enables shoppers to easily navigate retail environments by mapping products, offers, and shopping lists based on aisle location. It enhances the shopping experience by delivering contextually relevant information to consumers as they move through stores. For retailers, Aisle411's technology helps them engage shoppers at the shelf, facilitating access to product inventory and location data. The platform is designed to collect and organize this information, allowing for improved merchandising insights and customer engagement. Additionally, Aisle411 collaborates with leading indoor positioning technology providers to enhance its services, ultimately driving higher customer satisfaction and simplifying the overall shopping experience.

Yurbuds

Seed Round in 2012
Yurbuds exists to solve the problem that athletes face while wearing earphones. They don't hurt, and they are guaranteed to never fall out by taking advantage of its unique patented design developed by an Ironman Triathlete and a 24-time marathoner.

Decide

Seed Round in 2012
Decide operates an interest-based social platform that caters to various topics, including gaming, music, and politics. The company provides native advertising solutions that allow brands to effectively engage with their target audiences. It offers tools for audience development, such as polls, contests, quizzes, and feedback mechanisms, enabling publishers to activate user engagement through customizable actions like newsletter subscriptions and social media follows. Additionally, Decide assists in campaign planning, content creation, and performance optimization, while allowing real-time measurement of results. The platform leverages an in-house artificial intelligence, known as Neo, which utilizes machine learning to analyze vast amounts of data and make informed advertising decisions. Founded in 2008 and headquartered in Saint Louis, Missouri, with an additional office in New York, Decide aims to enhance the advertising experience by connecting advertisers with relevant publishers and users.

Euphrates Vascular

Series B in 2012
As of January 8, 2019, Pulse Therapeutics, Inc. was acquired by Ichor Vascular, Inc. Pulse Therapeutics, Inc., a medical technology company, develops magnetically-enhanced diffusion (MED) system for the treatment of stroke, heart, and other diseases. Its MED system is used to harness magnet-based technology to dissolve blood clots faster than current modalities. The company also provides MED MicroBeads that are designed to convey physician-selected agents faster to the blood clot; intravenously administered after thrombolysis therapy is initiated; and mechanical adjunct to standard of care IV thrombolysis. In addition, it offers touch screen operated MED Workstation. Pulse Therapeutics, Inc. was incorporated in 2008 and is based in St. Louis, Missouri.

Decide

Pre Seed Round in 2012
Decide operates an interest-based social platform that caters to various topics, including gaming, music, and politics. The company provides native advertising solutions that allow brands to effectively engage with their target audiences. It offers tools for audience development, such as polls, contests, quizzes, and feedback mechanisms, enabling publishers to activate user engagement through customizable actions like newsletter subscriptions and social media follows. Additionally, Decide assists in campaign planning, content creation, and performance optimization, while allowing real-time measurement of results. The platform leverages an in-house artificial intelligence, known as Neo, which utilizes machine learning to analyze vast amounts of data and make informed advertising decisions. Founded in 2008 and headquartered in Saint Louis, Missouri, with an additional office in New York, Decide aims to enhance the advertising experience by connecting advertisers with relevant publishers and users.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.